Clinical Trials Directory

Trials / Unknown

UnknownNCT04199962

Genomics in Infection and Sepsis to Predict Organ Dysfunction and Outcomes in Sepsis

Genomic Approaches for Predicting Severity of Organ Dysfunction and Outcomes in Sepsis: a Prospective Cohort Study in Adult Critically Ill Patients With Sepsis

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

This is a prospective cohort study using gene expression to study patients with infection and sepsis from pneumonia.

Detailed description

This is a prospective cohort study using single cell transcriptomic profiling and plasma DNA tissue mapping on patients with pneumonia with or without sepsis. The major application of the investigator's study would be the discovery of gene expressions in different leucocytes and plasma DNA associated with each type of organ dysfunction in sepsis. These include cardiovascular, respiratory, hepatic, renal, neurological and haematological dysfunction. This would help prediction, diagnosis and development of therapies to treat sepsis. Leucocyte single cell transcriptome and plasma DNA tissue mapping may addresses the limitations of current evidence in 3 ways: (1) differentiate patients with uncomplicated pneumonia versus pneumonia with associated sepsis, (2) correlation with types and severity of organ dysfunction and (3) identifying molecular phenotypes of sepsis.

Conditions

Timeline

Start date
2019-12-12
Primary completion
2022-11-11
Completion
2023-12-31
First posted
2019-12-16
Last updated
2021-01-29

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT04199962. Inclusion in this directory is not an endorsement.